Moreover, PACAP’s protective effects in MNs during ALS progression could be direct through PAC1R activation or mediated by EGFR trans-activation promoting MAPK or PI3K signaling survival cascade (Figure 5). This evidence concerns the gene ADCYAP1 and amyotrophic lateral sclerosis.